Recombinant Human CPT1B Protein，His

CPT1B (Carnitine Palmitoyltransferase 1B) is a crucial enzyme in the mitochondrial fatty acid oxidation pathway, playing a vital role in energy metabolism by facilitating the transport of long-chain fatty acids into the mitochondria. Abnormalities in CPT1B expression and function have been linked to various metabolic disorders, including obesity, insulin resistance, and certain cardiomyopathies. The study of CPT1B recombinant proteins has gained increasing attention in recent years as researchers seek to delineate its physiological roles and regulatory mechanisms. By using recombinant DNA technology, scientists can produce CPT1B in heterologous systems, allowing for detailed analyses of enzyme kinetics, substrate specificity, and potential post-translational modifications. Such studies are essential for understanding the molecular basis of CPT1B-related diseases and may pave the way for developing targeted therapeutic strategies. Furthermore, exploring the interactions of CPT1B with other metabolic pathways may provide insights into its broader effects on cellular energy homeostasis and overall metabolism. Consequently, research on CPT1B recombinant proteins not only enhances our understanding of lipid metabolism but also holds promise for advancing metabolic disease therapeutics.